Lessons from Season 3

Make Way for Advanced Therapies – Why Manufacturing Could be Coming to a Hospital Near You

Automation, Access, and the Future of Manufacturing

Scaling Cell & Gene Therapies: From Breakthroughs to the Mass Market

From Promise to Practice – AI's Impact on Cell and Gene Therapy Development

From Plastics to Partnerships - The Path to Sustainability in Biopharma

How Climate Change and AI are Driving Innovation in Biopharma

How Innovation Can Broaden Access and Propel the CGT Industry Forward

Why Do We Need to Continue Innovating in the CGT Industry?

Welcome Back to Invent: Life Sciences - Season 3 Trailer

The Highlights: A look back at the best moments of Invent: Life Sciences Series 2

Process Analytics: how can analytics accelerate the development and manufacture of cell and gene therapies?

iPSCs: how could stem cells revolutionise the manufacture of advanced therapies?

Sex and gender in medical research: how can a focus on the individual improve health outcomes for marginalised groups?

Organoids: how are in-vitro models revolutionising drug development and testing?

The Blood Brain Barrier: can innovations in delivery help us unlock the brain?

Small Molecules: can new classes of drug target reinvigorate drug discovery?

Cell and gene therapy: how can we transform artisan treatments into mass-market cures?

mRNA: What did Covid teach us about drug development and distribution?

Introducing Invent: Life Science Series 2